These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3302386)

  • 1. [Tissue factor and factor VII].
    Kobayashi N
    Rinsho Byori; 1987 Apr; Spec No 70():167-72. PubMed ID: 3302386
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of circulating tissue factor and factor VII in a normal population.
    Albrecht S; Kotzsch M; Siegert G; Luther T; Grossmann H; Grosser M; Müller M
    Thromb Haemost; 1996 May; 75(5):772-7. PubMed ID: 8725722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
    Hattori T; Khan MM; Colman RW; Edmunds LH
    J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assay for coagulation factor VII using factor VII-depleted bovine plasma.
    Nemerson Y; Clyne LP
    J Lab Clin Med; 1974 Feb; 83(2):301-3. PubMed ID: 4810955
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue factor revisited.
    Nemerson Y; Bach R
    Prog Hemost Thromb; 1982; 6():237-61. PubMed ID: 6762613
    [No Abstract]   [Full Text] [Related]  

  • 6. [Congenital lack of factor VII (author's transl)].
    Grosse KP; Neidhardt B; Seiler G; Schricker KT; Dorn G
    Klin Padiatr; 1974 Jan; 186(1):29-33. PubMed ID: 4857999
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation of canine factor VII deficient substrate plasma.
    Gaston LW; Spivack AR
    J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
    Morrissey JH
    Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S14-9. PubMed ID: 7647216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII.
    Peverill RE; Teede HJ; Smolich JJ; Malan E; Kotsopoulos D; Tipping PG; McGrath BP
    Clin Sci (Lond); 2001 Jul; 101(1):93-9. PubMed ID: 11410120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seminal factor VII and factor VIIa: supporting evidence for the presence of an active tissue factor-dependent coagulation pathway in human semen.
    Lwaleed BA; Goyal A; Delves G; Gossai S; Greenfield RS; Cooper AJ
    Int J Androl; 2007 Dec; 30(6):543-9. PubMed ID: 17459125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified two-stage assay method for tissue-thromboplastin (TPLN).
    Kale NR
    Thromb Diath Haemorrh; 1966 May; 15(3):403-12. PubMed ID: 4965683
    [No Abstract]   [Full Text] [Related]  

  • 12. Levels of activated factor VII in patients with disseminated intravascular coagulation.
    Saito M; Asakura H; Yoshida T; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
    Blood; 1995 Jun; 85(12):3770-1. PubMed ID: 7780163
    [No Abstract]   [Full Text] [Related]  

  • 13. The coagulation activity of the aortic wall in atherosclerosis.
    Nikitin YP
    Cor Vasa; 1969; 11(3):198-206. PubMed ID: 5355293
    [No Abstract]   [Full Text] [Related]  

  • 14. [Optimized methods for measuring coagulation factors II, IV, VII and X in cats].
    Mischke R; Deniz A; Nolte I
    Dtsch Tierarztl Wochenschr; 1994 Nov; 101(11):430-3. PubMed ID: 7895622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked increase of activated factor VII in uremic patients.
    Kario K; Matsuo T; Matsuo M; Koide M; Yamada T; Nakamura S; Sakata T; Kato H; Miyata T
    Thromb Haemost; 1995 May; 73(5):763-7. PubMed ID: 7482400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
    Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
    Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of factor VII on the assay of factor VIII by the one stage method using wettable surface.
    Altman R; Rouvier J; Reussi C
    Thromb Diath Haemorrh; 1972 Dec; 28(3):457-63. PubMed ID: 4675266
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors.
    Lee LC; Spittell JA; Sauer WG; Owen CA; Thompson JH
    Gastroenterology; 1968 Jan; 54(1):76-85. PubMed ID: 5638294
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue factor modulation of factor VIIa activity: use in measuring trace levels of factor VIIa in plasma.
    Morrissey JH
    Thromb Haemost; 1995 Jul; 74(1):185-8. PubMed ID: 8578455
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study.
    Miller GJ; Stirling Y; Esnouf MP; Heinrich J; van de Loo J; Kienast J; Wu KK; Morrissey JH; Meade TW; Martin JC
    Thromb Haemost; 1994 Jan; 71(1):38-48. PubMed ID: 8165645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.